Orbimed Advisors as of June 30, 2016
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 133 positions in its portfolio as reported in the June 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Boston Scientific Corporation (BSX) | 5.6 | $541M | 23M | 23.37 | |
Amgen (AMGN) | 4.8 | $462M | 3.0M | 152.15 | |
Abbvie (ABBV) | 4.2 | $407M | 6.6M | 61.91 | |
Bristol Myers Squibb (BMY) | 3.9 | $372M | 5.1M | 73.55 | |
Biogen Idec (BIIB) | 3.8 | $363M | 1.5M | 241.82 | |
Alexion Pharmaceuticals | 3.6 | $348M | 3.0M | 116.76 | |
Allergan | 3.6 | $345M | 1.5M | 231.09 | |
Hca Holdings (HCA) | 3.3 | $316M | 4.1M | 77.01 | |
Gilead Sciences (GILD) | 2.7 | $256M | 3.1M | 83.42 | |
Celgene Corporation | 2.5 | $237M | 2.4M | 98.63 | |
WellCare Health Plans | 2.1 | $206M | 1.9M | 107.28 | |
Thermo Fisher Scientific (TMO) | 2.1 | $204M | 1.4M | 147.76 | |
Intuitive Surgical (ISRG) | 2.1 | $197M | 298k | 661.41 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.0 | $188M | 2.2M | 86.02 | |
Incyte Corporation (INCY) | 1.9 | $186M | 2.3M | 79.98 | |
Regeneron Pharmaceuticals (REGN) | 1.9 | $178M | 510k | 349.23 | |
UnitedHealth (UNH) | 1.8 | $171M | 1.2M | 141.20 | |
Impax Laboratories | 1.8 | $170M | 5.9M | 28.82 | |
Intercept Pharmaceuticals In | 1.7 | $160M | 1.1M | 142.68 | |
Agilent Technologies Inc C ommon (A) | 1.6 | $158M | 3.6M | 44.36 | |
Pfizer (PFE) | 1.6 | $149M | 4.2M | 35.21 | |
Teva Pharmaceutical Industries (TEVA) | 1.4 | $139M | 2.8M | 50.23 | |
Relypsa | 1.4 | $137M | 7.4M | 18.50 | |
Ironwood Pharmaceuticals (IRWD) | 1.4 | $130M | 9.9M | 13.07 | |
Express Scripts Holding | 1.3 | $129M | 1.7M | 75.80 | |
Medivation | 1.3 | $121M | 2.0M | 60.30 | |
Wright Medical Group Nv | 1.3 | $121M | 6.9M | 17.37 | |
Illumina (ILMN) | 1.2 | $119M | 846k | 140.38 | |
BioMarin Pharmaceutical (BMRN) | 1.2 | $118M | 1.5M | 77.80 | |
Eli Lilly & Co. (LLY) | 1.2 | $116M | 1.5M | 78.75 | |
Cooper Companies | 1.2 | $116M | 676k | 171.57 | |
Merck & Co (MRK) | 1.1 | $110M | 1.9M | 57.61 | |
Molina Healthcare (MOH) | 1.1 | $109M | 2.2M | 49.90 | |
Ophthotech | 1.1 | $110M | 2.1M | 51.03 | |
Zimmer Holdings (ZBH) | 1.1 | $104M | 863k | 120.38 | |
Johnson & Johnson (JNJ) | 1.0 | $94M | 778k | 121.30 | |
Achillion Pharmaceuticals | 0.9 | $91M | 12M | 7.80 | |
Puma Biotechnology (PBYI) | 0.9 | $88M | 3.0M | 29.79 | |
Allergan Plc pfd conv ser a | 0.9 | $87M | 104k | 833.58 | |
Glaukos (GKOS) | 0.9 | $85M | 2.9M | 29.16 | |
Neurocrine Biosciences (NBIX) | 0.9 | $83M | 1.8M | 45.45 | |
Mallinckrodt Pub | 0.8 | $80M | 1.3M | 60.78 | |
Corvus Pharmaceuticals (CRVS) | 0.8 | $77M | 5.4M | 14.26 | |
Shire | 0.8 | $73M | 394k | 184.08 | |
Magellan Health Services | 0.8 | $72M | 1.1M | 65.77 | |
Humana (HUM) | 0.6 | $61M | 340k | 179.88 | |
Insys Therapeutics | 0.6 | $61M | 4.7M | 12.94 | |
Medtronic (MDT) | 0.6 | $58M | 666k | 86.77 | |
Intellia Therapeutics (NTLA) | 0.6 | $57M | 2.7M | 21.35 | |
Bluebird Bio (BLUE) | 0.5 | $51M | 1.2M | 43.29 | |
Edwards Lifesciences (EW) | 0.5 | $51M | 511k | 99.73 | |
Loxo Oncology | 0.5 | $50M | 2.2M | 23.18 | |
Insmed (INSM) | 0.5 | $43M | 4.4M | 9.86 | |
Spdr S&p 500 Etf (SPY) | 0.4 | $42M | 200k | 209.47 | |
CIGNA Corporation | 0.4 | $42M | 330k | 127.99 | |
SPDR S&P Biotech (XBI) | 0.4 | $40M | 745k | 54.08 | |
Eagle Pharmaceuticals (EGRX) | 0.4 | $40M | 1.0M | 38.79 | |
Array BioPharma | 0.4 | $39M | 11M | 3.56 | |
Dynavax Technologies (DVAX) | 0.4 | $35M | 2.4M | 14.58 | |
Intra Cellular Therapies (ITCI) | 0.4 | $34M | 885k | 38.82 | |
Dimension Therapeutics | 0.3 | $32M | 5.4M | 6.00 | |
Viewray (VRAYQ) | 0.3 | $33M | 8.0M | 4.09 | |
Otonomy | 0.3 | $29M | 1.9M | 15.88 | |
Ascendis Pharma A S (ASND) | 0.3 | $29M | 2.2M | 13.27 | |
Lion Biotechnologies | 0.3 | $27M | 3.4M | 8.10 | |
Stryker Corporation (SYK) | 0.3 | $25M | 212k | 119.83 | |
EXACT Sciences Corporation (EXAS) | 0.3 | $26M | 2.1M | 12.25 | |
Selecta Biosciences | 0.3 | $26M | 1.8M | 13.99 | |
Tenet Healthcare Corporation (THC) | 0.3 | $25M | 915k | 27.64 | |
Synergy Pharmaceuticals | 0.2 | $23M | 6.0M | 3.80 | |
Immunomedics Inc note 4.750% 2/1 | 0.2 | $21M | 30M | 0.69 | |
ImmunoGen | 0.2 | $19M | 6.1M | 3.08 | |
Galapagos Nv- (GLPG) | 0.2 | $20M | 353k | 55.47 | |
eHealth (EHTH) | 0.2 | $18M | 1.3M | 14.02 | |
Newlink Genetics Corporation | 0.2 | $18M | 1.6M | 11.26 | |
Cynapsus Therapeutics | 0.2 | $18M | 1.1M | 15.32 | |
Sinovac Biotech (SVA) | 0.2 | $16M | 2.7M | 5.93 | |
Xencor (XNCR) | 0.2 | $17M | 871k | 18.99 | |
D Fluidigm Corp Del (LAB) | 0.2 | $16M | 1.7M | 9.03 | |
Natera (NTRA) | 0.2 | $15M | 1.3M | 12.06 | |
Aetna | 0.1 | $14M | 117k | 122.13 | |
NuVasive | 0.1 | $15M | 247k | 59.72 | |
Forward Pharma A/s | 0.1 | $15M | 798k | 18.17 | |
Cardinal Health (CAH) | 0.1 | $13M | 166k | 78.01 | |
iShares NASDAQ Biotechnology Index (IBB) | 0.1 | $14M | 53k | 257.34 | |
Jazz Pharmaceuticals (JAZZ) | 0.1 | $13M | 90k | 141.31 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $11M | 2.3M | 4.84 | |
Pieris Pharmaceuticals | 0.1 | $12M | 7.3M | 1.61 | |
Inotek Pharmaceuticals | 0.1 | $10M | 1.4M | 7.44 | |
Abbott Laboratories (ABT) | 0.1 | $9.3M | 237k | 39.31 | |
Affimed Therapeutics B V | 0.1 | $9.4M | 3.8M | 2.48 | |
Cellectis S A (CLLS) | 0.1 | $9.3M | 350k | 26.59 | |
Nabriva Therapeutics | 0.1 | $9.9M | 1.3M | 7.50 | |
Immunomedics | 0.1 | $8.8M | 3.8M | 2.32 | |
Portola Pharmaceuticals | 0.1 | $8.8M | 371k | 23.60 | |
Ultragenyx Pharmaceutical (RARE) | 0.1 | $8.3M | 169k | 48.91 | |
Sientra | 0.1 | $8.9M | 1.4M | 6.58 | |
McKesson Corporation (MCK) | 0.1 | $8.1M | 43k | 186.66 | |
Alkermes (ALKS) | 0.1 | $7.4M | 172k | 43.22 | |
Assembly Biosciences | 0.1 | $7.8M | 1.4M | 5.55 | |
Syndax Pharmaceuticals (SNDX) | 0.1 | $7.5M | 757k | 9.85 | |
Incyte Corp. note 1.250 11/1 | 0.1 | $7.2M | 4.3M | 1.69 | |
Incyte Corp note 0.375%11/1 | 0.1 | $7.1M | 4.3M | 1.66 | |
Aeglea Biotherapeutics | 0.1 | $6.6M | 1.4M | 4.86 | |
C.R. Bard | 0.1 | $5.4M | 23k | 235.17 | |
Redhill Biopharma Ltd cmn | 0.1 | $6.1M | 565k | 10.87 | |
Fluidigm Corporation convertible cor | 0.1 | $6.1M | 10M | 0.61 | |
Adaptimmune Therapeutics (ADAP) | 0.1 | $5.9M | 724k | 8.15 | |
Infinity Pharmaceuticals (INFIQ) | 0.1 | $4.3M | 3.3M | 1.33 | |
Valeant Pharmaceuticals Int | 0.0 | $3.9M | 195k | 20.14 | |
Advaxis | 0.0 | $3.6M | 445k | 8.09 | |
Macrogenics (MGNX) | 0.0 | $4.0M | 149k | 26.99 | |
Invitae (NVTAQ) | 0.0 | $3.4M | 457k | 7.39 | |
Minerva Neurosciences | 0.0 | $3.3M | 322k | 10.21 | |
Seres Therapeutics (MCRB) | 0.0 | $2.5M | 86k | 29.05 | |
Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.0 | $2.5M | 12M | 0.21 | |
Uniqure Nv (QURE) | 0.0 | $1.4M | 195k | 7.37 | |
Roka Bioscience | 0.0 | $1.8M | 3.2M | 0.57 | |
Orexigen Therapeutics Inc. 144a 2 3/4% Due 12/1/2020 Jd1 note 2.750%12/0 | 0.0 | $2.2M | 5.2M | 0.42 | |
Amedisys (AMED) | 0.0 | $1.0M | 20k | 50.50 | |
Qlt | 0.0 | $710k | 500k | 1.42 | |
Amarin Corporation (AMRN) | 0.0 | $756k | 350k | 2.16 | |
Pernix Therapeutics Holdings | 0.0 | $483k | 1.1M | 0.45 | |
Biolinerx Ltd-spons | 0.0 | $831k | 1.0M | 0.80 | |
Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.0 | $555k | 500k | 1.11 | |
Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.0 | $580k | 500k | 1.16 | |
Marinus Pharmaceuticals | 0.0 | $1.1M | 868k | 1.27 | |
Cogentix Medical | 0.0 | $951k | 991k | 0.96 | |
Xtant Med Holdings | 0.0 | $908k | 475k | 1.91 | |
Medigus | 0.0 | $1.1M | 600k | 1.82 | |
Alimera Sciences | 0.0 | $308k | 250k | 1.23 | |
Aralez Pharmaceuticals | 0.0 | $225k | 68k | 3.30 | |
Beigene (BGNE) | 0.0 | $385k | 13k | 29.79 |